When should intravenous lidocaine be used for pain control?

When to Use Intravenous Lidocaine for Pain Control

Intravenous lidocaine should be used primarily for postoperative pain control in the peri-operative period, particularly for abdominal surgeries, as part of a multimodal analgesic strategy when institutional protocols are in place and appropriate monitoring is available. 1

Primary Indication: Postoperative Pain

The strongest evidence supports IV lidocaine for acute postoperative pain management, specifically:

• Abdominal surgeries (laparoscopic and open procedures) 2, 3
• Colorectal resections (minimally invasive techniques) 2
• Other surgical contexts including spinal, breast, and ENT procedures 3

The 2021 international consensus statement was developed specifically after a patient death, emphasizing that this is a high-risk intervention requiring strict protocols 1.

Clinical Benefits Demonstrated

IV lidocaine provides:

• Reduced postoperative nausea and vomiting (RR = 0.66) 2
• Faster return of bowel function (12.65 hours earlier for first bowel movement) 2
• Lower pain scores at 24 hours (MD = -1.61) 2
• Anti-inflammatory and anti-hyperalgesic effects through NMDA receptor blockade 1

Important caveat: IV lidocaine does NOT significantly reduce postoperative ileus, hospital length of stay, or opioid consumption 2.

Mandatory Prerequisites Before Use

Institutional Requirements

• Hospital governance approval required - medication committee must ratify use 1
• Standard operating procedures must be established
• Staff training on toxicity recognition mandatory 1

Patient Selection Criteria

Exclude patients with:

• Weight < 40 kg 1
• Severe hepatic disease (cannot metabolize lidocaine) 4
• Severe heart block 4
• Concurrent or recent local anesthetic use (see timing restrictions below) 1

Use extreme caution in:

• Elderly or debilitated patients 4
• Impaired cardiovascular function 4
• Sepsis or traumatized mucosa 4

Required Monitoring and Resources

• HDU/Level 2 care outside operating theatre/recovery 1
• Continuous ECG and pulse oximetry during loading 1
• Blood pressure every 5 minutes during initial infusion, then every 15 minutes 1
• Lipid emulsion 20% immediately available for toxicity treatment 1
• Dedicated infusion pump with anti-siphon mechanisms 1
• Separate dedicated IV cannula 1

Dosing Protocol

Loading Dose

• Maximum 1.5 mg/kg (ideal body weight) over 10 minutes 1
• Anaesthetist must be present during loading 1
• Complete before skin incision when possible 1

Maintenance Infusion

• 1.5 mg/kg/hour (ideal body weight) 1
• Maximum 120 mg/hour regardless of weight 1
• Duration: maximum 24 hours 1
• Extension beyond 24 hours requires consultant decision and 50% dose reduction 1

Critical Timing Restrictions with Other Local Anesthetics

IV lidocaine must NOT be used concurrently with regional anesthesia due to cumulative toxicity risk 1:

• Do not start IV lidocaine within 4 hours of any nerve block, fascial plane block, or port site infiltration 1
• Do not perform nerve blocks until 4 hours after stopping IV lidocaine 1
• No boluses into wound/epidural catheters until 4 hours after stopping IV lidocaine 1
• Remove topical 5% lidocaine patches before starting infusion 1

Exception: Single-shot spinal anesthesia is acceptable (small local anesthetic dose) 1

Limited Role in Chronic Pain

For chronic pain conditions, evidence is mixed and generally weak 5:

• Good evidence: Chronic post-surgical pain as augmentation 5
• Limited evidence: CRPS, cancer pain 5
• Diagnostic use: May help identify sodium channel-responsive neuropathic pain, but data are sparse 6
• Relief rarely persists beyond infusion duration 6
• Restrict to patients unable to take oral sodium channel blockers 6

Acute Non-Surgical Pain

Evidence for acute non-surgical pain is inconsistent 7:

• Superior to morphine for renal colic and critical limb ischemia 7
• Equivalent to ketorolac for radicular back pain 7
• Superior to DHE but inferior to chlorpromazine for acute migraine 7

Larger prospective studies needed before routine recommendation 7.

Toxicity Recognition

Early warning signs (neurologic - appear first): 1, 4

• Peri-oral tingling
• Tinnitus
• Restlessness, anxiety
• Light-headedness
• Slurred speech, altered mental status

Late signs (cardiovascular): 1, 4

• Arrhythmias
• Hypotension
• Cardiac arrest

Methemoglobinemia risk: 4

• Cyanotic skin discoloration
• Abnormal blood coloration
• May occur immediately or hours after exposure
• Higher risk: G6PD deficiency, infants < 6 months, cardiac/pulmonary compromise

Treatment: Discontinue immediately, supportive care, methylene blue for severe cases 4

Common Pitfalls to Avoid

1. Using actual body weight instead of ideal body weight for dosing calculations 1
2. Starting infusion too close to regional anesthesia - maintain 4-hour separation 1
3. Inadequate monitoring - patients require HDU-level care outside theatre 1
4. Lack of lipid emulsion availability - must be immediately accessible 1
5. Extending beyond 24 hours without consultant approval and dose reduction 1
6. Using in patients < 40 kg - contraindicated 1
7. Attributing symptoms to other causes when toxicity should be considered 1